Promotional price valid on web orders only. Your contract pricing may differ. Interested in signing up for a dedicated account number?
Learn More
Learn More
iNOS Antibody (4E5) - BSA Free, Novus Biologicals™

Mouse Monoclonal Antibody has been used in 19 publications
Supplier: Novus Biologicals NBP222119
Description
iNOS Monoclonal specifically detects iNOS in Human, Mouse samples. It is validated for Western Blot, Flow Cytometry, ELISA, Immunohistochemistry, Immunohistochemistry-Paraffin, Immunohistochemistry-Frozen, Flow (Intracellular).Specifications
iNOS | |
Monoclonal | |
1.0 mg/mL | |
Western Blot 1:500-1:2000, Flow Cytometry 1:200-1:400, ELISA 1:10000, Immunohistochemistry reported in scientific literature (PMID 29891729), Immunohistochemistry-Paraffin 1:200-1:1000, Immunohistochemistry-Frozen reported in scientific literature (PMID 32780728), Flow (Intracellular) | |
EC 1.14.13.39, Hepatocyte NOS, HEP-NOS, Inducible NO synthase, Inducible NOS, INOS, nitric oxide synthase 2, inducible, nitric oxide synthase 2A (inducible, hepatocytes), nitric oxide synthase, inducible, nitric oxide synthase, macrophage, NOS, NOS type II, NOS2A, Peptidyl-cysteine S-nitrosylase NOS2 | |
Mouse | |
131 kDa | |
0.1 mL | |
Adaptive Immunity, Apoptosis, Cancer, HIF Target Genes, Hypoxia, Inflammation, Lipid and Metabolism, Neuroscience, Neurotransmission | |
4843 | |
Store at 4C short term. Aliquot and store at -20C long term. Avoid freeze-thaw cycles. | |
IgG1 |
Western Blot, Flow Cytometry, ELISA, Immunohistochemistry, Immunohistochemistry (Paraffin) | |
400000 | |
Unconjugated | |
P35228 | |
NOS2 | |
iNOS Antibody (4E5) was made to a purified recombinant fragment of human iNOS (C-terminus) expressed in E. coli. [UniProt# P35228] | |
Ammonium sulfate precipitation | |
RUO | |
Primary | |
Human, Mouse | |
Precipitation |
Product Content Correction
Your input is important to us. Please complete this form to provide feedback related to the content on this product.
Product Title
For Research Use Only
Spot an opportunity for improvement?Share a Content Correction